List of works - Fabio Macaluso

A Propensity Score Weighted Comparison of Vedolizumab and Adalimumab in Crohn's Disease

scientific article published on 19 May 2020

A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

scientific article published on 01 February 2019

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

scientific article published on 22 June 2018

Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease

scientific article published on 27 December 2018

Antimitochondrial antibody -M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C.

scientific article published in April 2012

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

scientific article published on 25 March 2013

Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.

scientific article published on 7 October 2013

Cardiovascular diseases and HCV infection: a simple association or more?

scientific article published on 02 December 2013

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort

scientific article published on 16 October 2016

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease.

scientific article published on 17 January 2017

Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study

scientific article published on December 2013

Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study

scientific article published on 16 September 2014

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

scientific article published on April 2014

Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.

scientific article published on 2 March 2017

Education and Imaging. Hepatobiliary and pancreatic: Portal hypertensive biliopathy presenting as acute cholangitis.

scientific article published in August 2013

Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

scientific article published on 09 August 2020

Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis

scientific article published on 01 May 2019

Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.

scientific article

Genetic background in nonalcoholic fatty liver disease: A comprehensive review

scientific article

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

scientific article published on 30 January 2011

Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies.

scientific article published on 16 September 2015

Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report

scientific article published on December 2013

Herbal hepatotoxicity: a hidden epidemic.

scientific article published on 04 April 2012

How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey

article

Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection

scientific article published on 5 July 2012

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

scientific article published on 6 August 2013

Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?

scientific article published on 20 October 2017

Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2

scientific article published on 01 January 2019

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.

scientific article published in August 2016

Letter: mesalazine-a safe drug with rare serious adverse events

scientific article published on 01 June 2020

Letter: propensity score-handle with care

scientific article published on 01 January 2021

Letter: psoriasiform eruption during vedolizumab therapy

scientific article published on 01 August 2019

Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure.

scientific article

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

scientific article published on 01 April 2018

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

scientific article published on 14 October 2016

Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature

scientific article

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.

scientific article

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

scientific article published on 23 July 2014

Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease

Prevalence and incidence of inflammatory bowel disease in two Italian islands, Sicily and Sardinia: A report based on health information systems

scientific article published on 05 June 2019

Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.

scientific article published on May 2013

Psoriasis and Inflammatory Bowel Disease

scientific article published on 10 May 2019

Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.

scientific article published on June 2015

Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review

scientific article published on 06 February 2019

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

scientific article published on 15 June 2017

Screening of colorectal cancer: present and future.

scientific article published on 12 October 2017

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

scientific article published on 9 May 2014

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients

scientific article published on 05 December 2018

TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.

scientific article published on 17 July 2015

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.

scientific article published in January 2018

The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?

scientific article published on 28 May 2016

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches

scientific article published on 21 February 2020

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

scientific article

The VERSIFY Trial: What About Ultrasound Assessment?

scientific article published on 10 December 2019

The biologics of ulcerative colitis

scientific article published on 14 December 2016

The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients

scientific article published in January 2015

The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases

scientific article published on 01 March 2018

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

article

Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience

scientific article published on 29 May 2017

List of works by Fabio Macaluso

A Propensity Score Weighted Comparison of Vedolizumab and Adalimumab in Crohn's Disease

A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease

Antimitochondrial antibody -M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C.

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.

Cardiovascular diseases and HCV infection: a simple association or more?

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease.

Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study

Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.

Education and Imaging. Hepatobiliary and pancreatic: Portal hypertensive biliopathy presenting as acute cholangitis.

Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre study

Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis

Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.

Genetic background in nonalcoholic fatty liver disease: A comprehensive review

Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection

Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies.

Hepatocellular carcinoma and synchronous liver metastases from colorectal cancer in cirrhosis: A case report

Herbal hepatotoxicity: a hidden epidemic.

How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey

Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection

Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?

Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.

Letter: mesalazine-a safe drug with rare serious adverse events

Letter: propensity score-handle with care

Letter: psoriasiform eruption during vedolizumab therapy

Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure.

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease

Prevalence and incidence of inflammatory bowel disease in two Italian islands, Sicily and Sardinia: A report based on health information systems

Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist.

Psoriasis and Inflammatory Bowel Disease

Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.

Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

Screening of colorectal cancer: present and future.

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients

TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.

The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

The VERSIFY Trial: What About Ultrasound Assessment?

The biologics of ulcerative colitis

The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients

The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience